Arthur Henry Willms

This profile gathers the share dealings of Arthur Henry Willms in Cardiome Pharma Corp. In total, 4 filings cover trades dated from 22 June 2015 to 25 August 2017.

Every open-market trade on record is a purchase: 3 purchases worth €46k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2017: 1 purchase and no sales on the market.

A typical purchase (the median) is worth €14k. No cluster: in 3 purchases, no other insider of the company bought within 30 days.

The latest filing, published on 25 August 2017, reports an open-market purchase of €19k in Cardiome Pharma Corp. Between a trade and the moment it shows up on SEDI, the median delay is 1 day. The shorter that gap, the sooner other investors can see what insiders have done. This summary is built from SEDI disclosures alone and does not predict where the share price will go.